These immune components are responsible for production of inhibitory cytokines such as interleukin 10 (IL-10) and transforming growth factor-β (TGF-β), which may lower the risk of developing clinically significant autoimmune disease [18,19]. This evidence concerns the gene TGFB1 and autoimmune disease.